-
公开(公告)号：EP1404304B1
公开(公告)日：2009-05-27
申请号：EP02743173.3
申请日：2002-06-10
申请人： UCB FARCHIM S.A.
IPC分类号： A61K9/20 , A61K31/495
CPC分类号： A61K31/137 , A61K9/209 , A61K31/495 , A61K2300/00
摘要： The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
-
2.发明公开
公开(公告)号：EP3122330A1
公开(公告)日：2017-02-01
申请号：EP15712898.4
申请日：2015-03-26
申请人： UCB FARCHIM, S.A.
CPC分类号： A61K31/495 , A61K9/0053 , A61K9/0056 , A61K9/0095 , A61K9/1623 , A61K9/1652 , A61K9/1676 , A61K9/5036 , A61K9/5047
摘要： The present invention relates to a pharmaceutical composition comprising levocetirizine. The invention relates specifically to a dry syrup formulation.
摘要翻译： 本发明涉及包含左西替利嗪的药物组合物。 本发明具体涉及一种干糖制剂。
-
公开(公告)号：EP1467715A1
公开(公告)日：2004-10-20
申请号：EP03729449.3
申请日：2003-01-14
申请人： UCB Farchim S.A.
IPC分类号： A61K9/20 , A61K31/495 , A61K9/28 , A61K9/16 , A61K9/68
CPC分类号： A61K9/0095 , A61K9/0056 , A61K9/0058 , A61K9/2086 , A61K9/2826 , A61K31/495
摘要： The present invention relates to pharmaceutical compositions for oral administration of active compounds.
-
公开(公告)号：EP1467715B1
公开(公告)日：2010-11-03
申请号：EP03729449.3
申请日：2003-01-14
申请人： UCB FARCHIM S.A.
IPC分类号： A61K9/20 , A61K31/495 , A61K9/28 , A61K9/16 , A61K9/68
CPC分类号： A61K9/0095 , A61K9/0056 , A61K9/0058 , A61K9/2086 , A61K9/2826 , A61K31/495
摘要： The present invention relates to pharmaceutical compositions for oral administration of active compounds.
-
公开(公告)号：EP1569651A1
公开(公告)日：2005-09-07
申请号：EP03779899.8
申请日：2003-11-12
申请人： UCB FARCHIM S.A.
IPC分类号： A61K31/495 , A61K9/20 , A61K31/135
CPC分类号： A61K31/137 , A61K9/209 , A61K9/2866 , A61K31/4965 , A61K2300/00
摘要： The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
-
公开(公告)号：EP3122330B1
公开(公告)日：2018-07-25
申请号：EP15712898.4
申请日：2015-03-26
申请人： UCB FARCHIM, S.A.
IPC分类号： A61K9/00 , A61K9/50 , A61K31/495 , A61K9/16
CPC分类号： A61K31/495 , A61K9/0053 , A61K9/0056 , A61K9/0095 , A61K9/1623 , A61K9/1652 , A61K9/1676 , A61K9/5036 , A61K9/5047
摘要： The present invention relates to a pharmaceutical composition comprising levocetirizine. The invention relates specifically to a dry syrup formulation.
-
公开(公告)号：EP1569651B1
公开(公告)日：2008-07-30
申请号：EP03779899.8
申请日：2003-11-12
申请人： UCB FARCHIM S.A.
IPC分类号： A61K31/495 , A61K9/20 , A61K31/135
CPC分类号： A61K31/137 , A61K9/209 , A61K9/2866 , A61K31/4965 , A61K2300/00
摘要： The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
-
公开(公告)号：EP1768649A2
公开(公告)日：2007-04-04
申请号：EP05758582.0
申请日：2005-07-07
申请人： UCB FARCHIM S.A.
IPC分类号： A61K9/08 , A61K31/495
CPC分类号： A61K47/14 , A61K9/0043 , A61K9/0048 , A61K9/0095 , A61K31/495
摘要： The present invention relates to a liquid composition containing an active substance belonging to the family of substituted benzhydryl piperazines with reduced amounts of preservatives.
-
公开(公告)号：EP1465607B1
公开(公告)日：2007-03-21
申请号：EP03701497.4
申请日：2003-01-08
申请人： UCB FARCHIM S.A.
IPC分类号： A61K9/24 , A61K31/495
CPC分类号： A61K9/209 , A61K31/495
摘要： The invention relates to a pharmaceutical formulation to be administered orally, which contains efletirizine as an active principle and has a fast-release fraction and a timed-release fraction.
-
公开(公告)号：EP1404304A1
公开(公告)日：2004-04-07
申请号：EP02743173.3
申请日：2002-06-10
申请人： UCB Farchim S.A.
IPC分类号： A61K9/20 , A61K31/495
CPC分类号： A61K31/137 , A61K9/209 , A61K31/495 , A61K2300/00
摘要： The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.012 秒)
